We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCUT icon
3101
Lifetime Brands
LCUT
$193M
$1.11M ﹤0.01%
164,652
+26,827
+19% +$144K
LEVL
3102
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$1.1M ﹤0.01%
66,011
+2,054
+3% +$35.7K
EEX
3103
DELISTED
Emerald Holding
EEX
$1.1M ﹤0.01%
358,588
-21,849
-6% -$51.9K
FLXS icon
3104
Flexsteel Industries
FLXS
$312M
$1.1M ﹤0.01%
87,404
-45,449
-34% -$455K
FLNT
3105
Fluent
FLNT
$104M
$1.1M ﹤0.01%
103,203
+178
+0.2% +$1.99K
ORGS
3106
DELISTED
Orgenesis Inc. Common Stock
ORGS
$1.1M ﹤0.01%
18,029
+12,774
+243% +$773K
GNPX icon
3107
Genprex
GNPX
$2.4M
$1.09M ﹤0.01%
8
+5
+167% +$611K
TYME
3108
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$1.08M ﹤0.01%
812,334
+30,834
+4% +$42.1K
MVIS icon
3109
Microvision
MVIS
$89.2M
$1.07M ﹤0.01%
52,388
+9,774
+23% +$118K
HBB icon
3110
Hamilton Beach Brands
HBB
$334M
$1.06M ﹤0.01%
89,206
+4,110
+5% +$45K
EPM icon
3111
Evolution Petroleum
EPM
$131M
$1.05M ﹤0.01%
374,276
-14,135
-4% -$37.9K
RMNI icon
3112
Rimini Street
RMNI
$450M
$1.05M ﹤0.01%
203,169
+18,635
+10% +$79.3K
PROS
3113
DELISTED
ProSight Global, Inc.
PROS
$1.04M ﹤0.01%
117,154
+739
+0.6% +$6.71K
ORAN
3114
DELISTED
Orange
ORAN
$1.04M ﹤0.01%
87,403
-25,497
-23% -$304K
PHAS
3115
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1.04M ﹤0.01%
225,934
+11,275
+5% +$49.9K
TRVN
3116
DELISTED
Trevena, Inc.
TRVN
$1.03M ﹤0.01%
1,103
+56
+5% +$37.3K
VAL
3117
DELISTED
Valaris plc Class A Ordinary Share
VAL
$1.03M ﹤0.01%
1,582,205
-8,471
-0.5% -$4.79K
KLDO
3118
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$1.02M ﹤0.01%
137,860
+6,631
+5% +$44.4K
KLR.WS
3119
DELISTED
Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share
KLR.WS
$1.02M ﹤0.01%
1,576,208
-812,727
-34% -$689K
MFNC
3120
DELISTED
Mackinac Financial Corporation
MFNC
$1.02M ﹤0.01%
98,565
+4,751
+5% +$47K
RVP icon
3121
Retractable Technologies
RVP
$20.4M
$1.02M ﹤0.01%
144,851
+103,089
+247% +$477K
NYMX
3122
DELISTED
Nymox Pharmaceutical Corp
NYMX
$1.01M ﹤0.01%
284,830
+243,238
+585% +$769K
MG icon
3123
Mistras Group
MG
$487M
$1M ﹤0.01%
254,672
+5,600
+2% +$23.2K
REV
3124
DELISTED
Revlon, Inc.
REV
$1M ﹤0.01%
101,535
+201
+0.2% +$2.2K
AVEO
3125
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1M ﹤0.01%
195,026
+97,427
+100% +$615K

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.